跳至主要内容
临床试验/EUCTR2019-000403-32-NL
EUCTR2019-000403-32-NL进行中(未招募)1 期

The effect of lidocaïne injections in the m. vastus intermedius and the m. rectus femoris on the gait pattern in patients walking with stiff knee gait after a stroke. - lidocaine injections in the vastus intermedius and rectus femoris in stiff knee gait after a stroke

Roessingh Research and Development0 个研究点目标入组 18 人开始时间: 2019年7月17日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Age > 18 years old
  • - The stroke is more then six months ago
  • - Patient is walking with stiff knee gait (reduced knee flexion during swing fase)
  • - Patients is able to walk independently (FAC = 3)
  • - Overactivity of the m. vastus intermedius and m. rectus femoris (EMG)
  • - Patient is capable to understand and follow instructions
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 18
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Problems that influence the gait pattern that are not caused by the stroke
  • - Allergy or hypersensitivity for lidocaine or a previous allergic reaction to lidocaine
  • - Inflamation in the injection area

研究者

发起方
Roessingh Research and Development

相似试验